Kyntra Bio Inc KYNB

6.94 (0.06) (0.86%) as of 25 Sep
Market cap
$28.3M
P/E
0.2×
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
88.98 50.48 203.45 422.01 405.19 686.54 533.76 621.40 735.72 253.18
Receivables
0.22 0.48 5.12 16.30 17.40 41.88 28.46 63.68 8.45 10.45
Inventory
3.74 3.16 17.17 40.44 31.02 16.53 6.89 — — —
Other current assets
— 110.85 65.78 14.08 12.45 10.16 8.18 4.93 4.80 2.89
Total current assets
99.07 196.51 331.56 492.83 474.06 755.11 702.49 690.02 748.97 266.52
Property, Plant, Equpment (Net)
— — 4.79 20.61 28.28 33.65 42.74 127.20 129.48 123.66
Long-Term Investments
20.16 — 5.29 9.41 171.62 2.97 61.12 55.82 10.51 71.01
Long-term assets (Other)
0.36 18.02 22.25 7.35 8.75 3.46 11.44 7.57 9.70 8.37
Total non-current assets
20.52 18.02 91.97 117.26 299.76 71.73 154.91 190.58 149.68 203.04
Total Assets
119.59 214.53 423.53 610.09 773.82 826.84 857.40 880.60 898.65 469.55
Accounts Payable
3.75 5.06 15.78 30.76 26.10 24.79 6.09 9.14 5.51 6.22
Accrued Expenses
20.18 62.04 132.99 219.77 172.60 118.33 83.82 66.12 63.78 50.91
Current Part of Capital Lease
— — — — 0.01 12.33 12.35 — — —
Current Revenue (Deferred)
5.31 27.29 12.74 12.74 15.86 6.55 0.49 13.77 16.67 7.99
Other current liabilities
— 38.92 43.52 232.48 188.45 124.88 83.32 79.89 80.45 58.90
Total current liabilities
29.24 133.31 217.67 273.56 225.50 163.19 102.75 89.03 85.96 65.13
Long Term Debt (Total)
— 73.09 71.93 96.65 106.39 25.39 37.61 107.96 97.76 97.35
Non-current Revenue (Deferred)
0.26 114.71 157.56 185.72 186.80 138.47 99.45 139.15 141.90 110.92
Minority Interests
21.48 21.48 21.48 — — — — — — —
Non-current Liabilities (Other)
85.62 77.05 73.54 72.69 43.63 57.49 82.19 26.79 25.29 21.05
Total non-current liabilities
107.36 286.33 389.54 338.01 319.21 222.20 219.25 263.10 264.95 229.32
Total liabilities
136.60 419.64 607.21 611.57 544.71 385.39 321.99 352.13 350.91 294.44
Additional Paid In Capital
1,677.18 1,668.62 1,643.64 1,541.02 1,476.41 1,399.77 1,300.73 1,226.45 1,160.09 625.90
Common Stock (Net)
1.01 1.01 0.99 0.94 0.93 0.91 0.88 0.85 0.83 0.64
Retained Earnings
(1,706.05) (1,889.50) (1,841.92) (1,557.69) (1,264.03) (974.01) (784.72) (715.83) (630.66) (469.74)
Common Equity (Total)
(17.01) (205.11) (183.68) (1.48) 229.11 441.45 535.41 528.47 547.74 175.11
Shareholders Equity (Total)
(17.00) (205.11) (183.68) (1.48) 229.11 441.45 535.41 528.47 547.74 175.11
Shareholders Equity and Liabilities (Total)
119.59 214.53 423.53 610.09 773.82 826.84 857.40 880.60 898.65 469.55
Shares (Common)
4.05 4.04 3.95 3.77 3.72 3.66 3.51 3.42 3.30 2.55
Shareholders Equity (Tangible)
(17.00) (205.11) (183.68) (1.48) 229.11 441.45 535.41 528.47 547.74 175.11
Net Debt
(88.98) 22.61 (131.52) (325.36) (298.80) (661.15) (496.15) (513.45) (637.95) (155.83)
Total Debt
— 73.09 71.93 96.65 106.39 25.39 37.61 107.96 97.76 97.35

Fold the line items

In millions of $ except per-share values · columns are period end dates